Manufacturing Industry

Sunstone Pharmaceuticals, the Chinese subsidiary of US speciality pharma concern BMP Sunstone, is acquiring a 75% holding in Zhangjiakou Shengda Pharmaceutical, a Chinese manufacturer of paediatric pharmaceuticals and specialising in antibiotic R&D, for around $4.4m

Chemistry and Industry, August 11, 2008 by Neil Eisberg

Sunstone (Tangshan) Pharmaceuticals, the Chinese subsidiary of US speciality pharma concern BMP Sunstone, is acquiring a 75% holding in Zhangjiakou Shengda Pharmaceutical, a Chinese manufacturer of paediatric pharmaceuticals and specialising in antibiotic R&D, for around $4.4m. The terms of the deal, which is expected to be closed during Q4 2008, have yet to be finalised.

Sunstone recently acquired a 63.3% holding in Shanghai Rongheng Pharmaceutical.

COPYRIGHT 2008 Society of Chemical Industry
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale